4HF Biotec is thrilled to participate in this year’s MEET2WIN in Bordeaux on May 16-17, 2024. Anne-Lise Peille, head of target development, and Thomas Metz, Chief Business Officer, are excited about creating new collaborations for our oncology drug development projects and R&D support services. Contact us to schedule a meeting! …
Discover the latest from 4HF Biotec at the AACR Annual meeting in San Diego. 4HF will present two exciting posters showcasing its newest advancements in the bioinformatic identification of targets and how its in silico tools can work in tandem with experimental data to gather insights about drug conjugates: 4HF …
4HF Biotec is focusing on the development of innovative small molecule-based targeted therapeutics for oncology. To identify and design innovative drugs, 4HF Biotec launched a fully integrated AI-based drug discovery platform to facilitate and accelerate the development its drug candidate pipeline. 4HF Biotec’s cancer targets are issued from our internal …